Effect of herpes zoster vaccine and antiviral treatment on risk of ischemic stroke. [PDF]
Neurology, 2020 Objective To determine whether increased risk of acute ischemic stroke (AIS) following herpes zoster (HZ) might be modified by the status of zoster vaccine live (ZVL) vaccination and antiviral treatment following HZ.
Yang Q +5 more
europepmc +2 more sources
Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib. [PDF]
Ann Rheum Dis, 2020 Herpes zoster (HZ) incidence is higher in patients with rheumatoid arthritis (RA) compared with the general population,1 and it may be further increased with disease-modifying antirheumatic drugs (DMARDs).2 Tofacitinib is an oral Janus kinase inhibitor ...
Winthrop KL +9 more
europepmc +2 more sources
Vaccines, 2023 Previous studies have shown that the herpes zoster subunit vaccine Shingrix™ performs well in clinical trials. However, the key ingredient in its adjuvant, QS21, is extracted from rare plants in South America, so vaccine production is limited.
Kangyang Lin +5 more
doaj +2 more sources
Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine. [PDF]
Clin Infect Dis, 2020 The adjuvanted recombinant glycoprotein E herpes zoster (HZ) vaccine is superior to the live attenuated HZ vaccine, with an efficacy >90% against HZ in healthy immunocompetent adults aged ≥50 years after vaccination.
Levin MJ, Weinberg A.
europepmc +2 more sources
Unraveling Herpes Zoster Vaccine Hesitancy, Acceptance, and Its Predictors: Insights From a Scoping Review [PDF]
Public Health ReviewsObjectivesHerpes zoster vaccination is critical in preventing herpes zoster virus infection and its associated consequences. Despite its relevance, global herpes zoster immunisation coverage remains alarmingly low.
Xiaolong Wang +7 more
doaj +2 more sources
Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023 [PDF]
Scientific ReportsVaccine-induced immunosuppression can reactivate the varicella-zoster virus, potentially leading to the development of herpes zoster. However, the literature on this topic is inconsistent, resulting in limited clarity.
Jinyoung Jeong +18 more
doaj +2 more sources
Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study. [PDF]
J Acquir Immune Defic Syndr, 2018 Background: Despite historically high rates of herpes zoster among people living with HIV (PLWH), comparative studies of herpes zoster by HIV serostatus are lacking since the advent of combination antiretroviral therapy and availability of zoster vaccine.
Hawkins KL +11 more
europepmc +2 more sources
Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster [PDF]
Arthritis Research & TherapyBackground Risk of cardiovascular events may increase after herpes zoster; therefore, American College of Rheumatology guidelines strongly recommend vaccination against herpes zoster in patients aged ≥ 18 years with rheumatic and musculoskeletal diseases
Jeffrey R. Curtis +4 more
doaj +2 more sources
The Journal of Infectious Diseases, 2021 Abstract Herpes zoster (HZ) affects approximately 1 in 3 persons in their lifetime, and the risk of HZ increases with increasing age. The most common, debilitating complication of HZ is the chronic neuropathic pain of postherpetic neuralgia (PHN).
Michael N. Oxman +4 more
openaire +3 more sources
Herpes zoster after COVID vaccination [PDF]
International Journal of Infectious Diseases, 2021 COVID-19 presents in various ways, but mainly as a pulmonary disease (Marzano, 2020). Skin manifestations have been reported, including reactivation of the varicella-zoster virus (Marzano, 2020). Our case report describes two adults developing herpes zoster after vaccination with tozinameran (the Pfizer-BioNTech COVID-19 mRNA vaccine). A possible cause
C.S. van Dam +5 more
openaire +3 more sources